Gyre Therapeutics GYRE
NASDAQ GYRE
$7.33 +0.01 (+0.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Dividends payables (2022)

Updated

Gyre Therapeutics' Dividends payables was $7.56 million in Q4 2022.

Analysis

Gyre Therapeutics (GYRE) Dividends payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.13 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.45 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Gyre Therapeutics 777.23 Mn 579.94 Mn 26.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 7.56 Mn
API Access

Gyre Therapeutics Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=GYRE&period=max&api_key=YOUR_API_KEY